VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.3529
-0.0127 (-3.47%)
At close: Aug 1, 2025, 4:00 PM
0.3550
+0.0021 (0.60%)
After-hours: Aug 1, 2025, 7:58 PM EDT

VYNE Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
64933955265
Upgrade
Market Cap Growth
-44.48%51.96%273.57%-84.05%-79.42%-
Upgrade
Enterprise Value
-44-2117-273224
Upgrade
Last Close Price
0.353.352.332.7018.36113.76
Upgrade
PS Ratio
24.8698.6476.7018.2558.6312.64
Upgrade
PB Ratio
0.130.950.370.281.127.08
Upgrade
P/TBV Ratio
0.130.950.370.281.127.08
Upgrade
EV/Sales Ratio
--40.27-3.5810.69
Upgrade
Debt / Equity Ratio
0.000.000.00-0.010.93
Upgrade
Asset Turnover
0.010.010.010.010.010.24
Upgrade
Inventory Turnover
-----0.32
Upgrade
Quick Ratio
4.094.1512.373.842.713.42
Upgrade
Current Ratio
4.474.3512.734.103.434.01
Upgrade
Return on Equity (ROE)
-66.15%-56.54%-46.40%-84.81%-102.66%-928.19%
Upgrade
Return on Assets (ROA)
-38.36%-33.14%-26.42%-39.77%-30.25%-81.10%
Upgrade
Return on Capital (ROIC)
-44.48%-38.65%-30.39%-53.32%-40.11%-114.09%
Upgrade
Earnings Yield
-717.49%-80.61%-87.49%-266.62%-134.33%-96.35%
Upgrade
FCF Yield
-638.82%-68.98%-77.92%-335.43%-103.26%-51.72%
Upgrade
Buyback Yield / Dilution
-111.95%-314.57%-222.44%-11.44%-58.75%-282.06%
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q